10-Q Filing

Xenetic Biosciences, Inc. CIK: 1534525 Q1 2020

Filing Information

Form Type	10-Q
Accession Number	`0001683168-20-001566`
Period End Date	20200331
Filing Date	20200514
Fiscal Year	2020
Fiscal Period	Q1
XBRL Instance	xbio-20200331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 52 Income Statement 26 Cash Flow Statement 42 Stockholders Equity 17

Balance Sheet 52 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	12.50M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	12.50M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	6.31M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	6.09M	shares	Point-in-time
Cash	`Cash`	$9.37M	USD	Point-in-time
Cash	`Cash`	$10.37M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	6.28M	shares	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$722.08K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	6.07M	shares	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$1.31M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$10.68M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$11.09M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$166.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$757.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Indefinite-lived intangible assets	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$9.24M	USD	Point-in-time
Indefinite-lived intangible assets	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$9.24M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.21M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$704.43K	USD	Point-in-time
Total assets	`Assets`	$20.63M	USD	Point-in-time
Total assets	`Assets`	$21.55M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$931.13K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.05M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$456.16K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$484.03K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.42M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.51M	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilitiesNoncurrent`	$2.92M	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilitiesNoncurrent`	$2.92M	USD	Point-in-time
Total liabilities	`Liabilities`	$4.33M	USD	Point-in-time
Total liabilities	`Liabilities`	$4.43M	USD	Point-in-time
Commitments (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value; 12,500,000 shares authorized as of March 31, 2020 and December 31, 2019; 6,311,906 and 6,092,432 shares issued as of March 31, 2020 and December 31, 2019, respectively; 6,284,915 and 6,065,441 shares outstanding as of March 31, 2020 and December 31, 2019, respectively	`CommonStockValue`	$6.09K	USD	Point-in-time
Common stock, $0.001 par value; 12,500,000 shares authorized as of March 31, 2020 and December 31, 2019; 6,311,906 and 6,092,432 shares issued as of March 31, 2020 and December 31, 2019, respectively; 6,284,915 and 6,065,441 shares outstanding as of March 31, 2020 and December 31, 2019, respectively	`CommonStockValue`	$6.31K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$188.24M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$188.41M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-166.01M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-167.19M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$253.73K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$253.73K	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$5.28M	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$5.28M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$17.21M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$16.20M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$11.52M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$9.91M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$21.55M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$20.63M	USD	Point-in-time

Income Statement 26 line items

Line Item	Tag	Value	Unit	Period
Total revenues	`Revenues`	-	USD	1 Quarter
Total revenues	`Revenues`	$56.75K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$463.78K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$359.65K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$927.88K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$863.37K	USD	1 Quarter
Total operating costs and expenses	`OperatingExpenses`	$1.29M	USD	1 Quarter
Total operating costs and expenses	`OperatingExpenses`	$1.33M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.33M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.23M	USD	1 Quarter
Other expense	`OtherNonoperatingIncomeExpense`	$-245.00	USD	1 Quarter
Other expense	`OtherNonoperatingIncomeExpense`	$-134.00	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNet`	$150.00	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNet`	$51.49K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-95.00	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$51.35K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.18M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.33M	USD	1 Quarter
Deemed dividend	`PreferredStockDividendsIncomeStatementImpact`	-	USD	1 Quarter
Deemed dividend	`PreferredStockDividendsIncomeStatementImpact`	$3.88M	USD	1 Quarter
Net loss applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.18M	USD	1 Quarter
Net loss applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-5.21M	USD	1 Quarter
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-6.45	USD	1 Quarter
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-0.19	USD	1 Quarter
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	6.23M	shares	1 Quarter
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	806,976.00	shares	1 Quarter

Cash Flow Statement 42 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-1.18M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.33M	USD	1 Quarter
Depreciation	`Depreciation`	$591.00	USD	1 Quarter
Depreciation	`Depreciation`	$1.46K	USD	1 Quarter
Amortization of right of use asset	`OtherDepreciationAndAmortization`	$6.82K	USD	1 Quarter
Amortization of right of use asset	`OtherDepreciationAndAmortization`	-	USD	1 Quarter
Gain on sale of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$2.00K	USD	1 Quarter
Gain on sale of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	1 Quarter
Share-based expense	`ShareBasedCompensation`	$216.51K	USD	1 Quarter
Share-based expense	`ShareBasedCompensation`	$165.60K	USD	1 Quarter
Vendor share-based payments	`VendorShareBasedPayments`	$17.43K	USD	1 Quarter
Vendor share-based payments	`VendorShareBasedPayments`	-	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInAccountsAndOtherReceivables`	$536.70K	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInAccountsAndOtherReceivables`	$86.45K	USD	1 Quarter
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$92.14K	USD	1 Quarter
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$376.03K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.00M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.25M	USD	1 Quarter
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	1 Quarter
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$2.00K	USD	1 Quarter
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$2.00K	USD	1 Quarter
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	1 Quarter
Net proceeds from issuance of common stock and warrants	`ProceedsFromIssuanceOrSaleOfEquity`	$2.70M	USD	1 Quarter
Net proceeds from issuance of common stock and warrants	`ProceedsFromIssuanceOrSaleOfEquity`	-	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.70M	USD	1 Quarter
Net change in cash and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$1.45M	USD	1 Quarter
Net change in cash and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-1.00M	USD	1 Quarter
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$638.12K	USD	Point-in-time
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.08M	USD	Point-in-time
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.37M	USD	Point-in-time
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.37M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$638.12K	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.08M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.37M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.37M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$8.00	USD	1 Quarter
Cash paid for interest	`InterestPaidNet`	-	USD	1 Quarter
Right of use assets obtained in exchange for lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$43.33K	USD	1 Quarter
Right of use assets obtained in exchange for lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	-	USD	1 Quarter
Issuance of common stock from cashless exercise of purchase warrants	`IssuanceOfCommonStockFromCashlessExerciseOfPurchaseWarrants`	-	USD	1 Quarter
Issuance of common stock from cashless exercise of purchase warrants	`IssuanceOfCommonStockFromCashlessExerciseOfPurchaseWarrants`	$219.00	USD	1 Quarter

Stockholders Equity 17 line items

Line Item	Tag	Value	Unit	Period
Beginning balance, value	`StockholdersEquity`	$17.21M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$16.20M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$11.52M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$9.91M	USD	Point-in-time
Issuance of common stock and warrants in registered direct offering, net of issuance costs, value	`IssuanceOfCommonStockAndWarrantsInMarch2019RegisteredDirectOfferingNetOfIssuanceCostsValue`	$2.70M	USD	1 Quarter
Exercise of purchase warrants, value	`ExerciseOfPurchaseWarrantsValue`	-	USD	1 Quarter
Deemed dividend related to Series B Preferred Stock down round provision	`DeemedDividendRelatedToSeriesBPreferredStockDownRoundProvision`	$3.88M	USD	1 Quarter
Accretion of deemed dividend related to Series B Preferred Stock down round provision	`OtherPreferredStockDividendsAndAdjustments`	$3.88M	USD	1 Quarter
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$165.60K	USD	1 Quarter
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$216.51K	USD	1 Quarter
Common stock awards to vendors	`AdjustmentsToAdditionalPaidInCapitalOther`	$17.43K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.18M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.33M	USD	1 Quarter
Ending balance, value	`StockholdersEquity`	$17.21M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$16.20M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$11.52M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$9.91M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.